http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009095057-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b25fdf906f220494e9adc078899aac7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4896b98f5df7601882ae4c83821e3556
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c32029b4b557790a8c108a72e9711bc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
filingDate 2008-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_766cfb74b413dbc6f9e59e1142d6dd41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08f7a916605fadbc48c6c0aba5f897ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c00ed65ec72ca8ef8989414ac8d83ee7
publicationDate 2009-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009095057-A2
titleOfInvention Transdermal therapeutic system having urea components
abstract The invention relates to a transdermal therapeutic system (TTS) for administering pharmaceutical agents through the skin, comprising a back layer (R) impermeable to the agent and at least one layer (S) comprising the agent, wherein the layer (H) facing the skin comprises urea in solid form, allowing continuous administration of large quantities of agent over a long period of time.
priorityDate 2008-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004047816-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0870498-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2867978-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128925071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409751
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127508829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129978672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128979884
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128344919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127963844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129836331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226508144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65997
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID229860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226493939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124

Total number of triples: 57.